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increase in the VEGFPLT value from 2.1 ± 1.0 pg during the
time of remission to 6.75 pg at the time of clinical relapse.
This increment in VEGFPLT could be due to a release of VEGF
from a fast-growing tumour mass and/or from tumour-
activated platelets (Pinedo et al, 1998). We did indeed find
tumour cells to induce platelet activation and release of VEGF
from activated platelets (manuscript in preparation).
In summary, we agree with Vermeulen and colleagues that
VEGF levels in serum may be a useful tumour marker that relates
to the disease stage, tumour progression and tumour-induced
platelet activation. To correctly interpret serum VEGF levels,
however, blood platelet counts and the platelet size must be taken
into consideration.
E Gunsilius and G Gastl
Division of Hematology and Oncology, University Hospital,
Anichstr. 35, 6020 Innsbruck, Austria
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Figure 1 Mean platelet volumes (MPV, black columns) and corresponding
VEGFPLT (hatched columns) in a patient undergoing myeloablative
chemotherapy. MPV before the platelet nadir (A) were lower than those
thereafter (B, P = 0.001). Also, the VEGFPLT are lower before the platelet
nadir (C) than thereafter (D). VEGFPLT correlated to the MPV (r = 0.59)
Effect of acetic acid on telomerase activity in
premalignant and malignant cervical lesions
Sir
We read with great interest the report by Mutirangura et al (1998)
on defining a correlation between telomerase activity and human
papillomavirus (HPV) in normal control tissue and in benign,
premalignant and malignant cervical lesions.
We are convinced of the conclusion that there may be two roles
of telomerase in the cervix (the first one would present in benign
lesions; the second is associated with cancer development and acti-
vated during the late stage of multistep carcinogenesis). However,
we have doubt about the low percentages of telomerase activity
reported for high-grade squamous intraepithelial lesions (SILs) as
40%, and probably for others, especially after reading the article by
Changchien et al (1998). The studies of many authors revealed that
25—58% of high-grade SILs exhibited telomerase activity (Kyo et
al, 1997; Pao et al, 1997; Zheng et al, 1997). However, Changchien
et al reported a relative high percentage of telomerase activity
(77.1%) in high-grade SILs. The large discrepancy between the
results of previous studies and the results of them were explained
by the methods of cervical tissue collection. They claimed that they
increased the detection rate of telomerase activity by making the
tissues submitted for telomerase assay free of acetic acid.
It is well known that swabbing of cervix with 3—5% acetic acid
is a crucial step when colposcopy is performed. Since some of the
samples of Mutirangura et al were also obtained by this way, those
samples could have been affected by acetic acid. Due to the reason
that pH of 5% acetic acid is too low and exposure time is too long,
telomerase protein is probably irreversibly denatured by this
process (Lodish et al, 1995).
We would like to stress that if ￿acetic acid￿ factor is taken into
consideration in such studies, much higher telomerase detection
rates and eventually much more accurate results of it are possible
to be obtained.
IH Güllü and M Kurdog ˘lu
Institute of Oncology, Hacettepe University, Sihhiye 06100,
Ankara, Turkey.
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